Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtre
Ajouter des filtres








Gamme d'année
2.
Indian J Physiol Pharmacol ; 1998 Apr; 42(2): 295-8
Article Dans Anglais | IMSEAR | ID: sea-106967

Résumé

The effect of pretreatment with graded concentration of diltiazem on the inotropic responses to amrinone were studied on isolated atria of rabbit. The responses to amrinone were modified by diltiazem in a biphasic manner; initial potentiation followed by inhibition. The potentiation is proposed to be due to synergistic rise in cytosolic calcium ion concentration by diltiazem and amrinone. The inhibition by diltiazem in higher concentration may be due to blockade of calcium ion influx and depletion of intracellular calcium ion from storage sites.


Sujets)
Amrinone/pharmacologie , Animaux , Fonction auriculaire , Inhibiteurs des canaux calciques/pharmacologie , Cardiotoniques/pharmacologie , Diltiazem/pharmacologie , Synergie des médicaments , Atrium du coeur/effets des médicaments et des substances chimiques , Contraction myocardique/effets des médicaments et des substances chimiques , Inhibiteurs de la phosphodiestérase/pharmacologie , Lapins
3.
Indian J Physiol Pharmacol ; 1995 Jul; 39(3): 293-5
Article Dans Anglais | IMSEAR | ID: sea-107778

Résumé

In a double blind short term clinical study, nitroxazepine has been found to be superior over placebo in reducing the diastolic blood pressure in mild hypertensive patients. In short term open clinical trial design nitroxazepine (25 mg PO, HS) has been found to be superior and better tolerated than diazepam (5 mg PO, HS). In open clinical trial design, nitroxazepine (25 mg PO, HS) reduced the diastolic blood pressure to the target level (100 mm Hg and less) effectively controlling the uncontrolled hypertensive patients receiving maintenance dose of beta blockers. There was no such beneficial effect in patients receiving maintenance doses of other antihypertensive drugs (pilot study). Adverse drug reactions like disturbed sleep in one, uneasiness in 3, palpitation in one and dryness of mouth in one patient have been observed.


Sujets)
Antagonistes bêta-adrénergiques/usage thérapeutique , Adulte , Antihypertenseurs/effets indésirables , Pression sanguine/effets des médicaments et des substances chimiques , Diazépam/effets indésirables , Dibenzoxazépines/effets indésirables , Méthode en double aveugle , Humains , Hypertension artérielle/traitement médicamenteux , Projets pilotes
4.
Indian J Physiol Pharmacol ; 1995 Jan; 39(1): 83-5
Article Dans Anglais | IMSEAR | ID: sea-107732

Résumé

Diltiazem, a calcium channel blocker was studied to observe its effects on the acetylcholine contractile responses of isolated frog rectus abdominis muscle. This response was modified in a dual manner i.e., initial potentiation, followed by inhibition. Diltiazem may not have anticholinesterase like mechanism, as it potentiated the responses to both acetylcholine and succinylcholine. Rectus muscle preparation, incubated in calcium free frog Ringer, showed dose dependent inhibition of acetylcholine contractile responses by diltiazem. The study suggests that diltiazem inhibits calcium ion influx across receptor operated calcium channels and may also inhibit calcium ion release from intracellular structures.


Sujets)
Acétylcholine/antagonistes et inhibiteurs , Animaux , Anura , Calcium/métabolisme , Canaux calciques/effets des médicaments et des substances chimiques , Diltiazem/pharmacologie , Relation dose-effet des médicaments , Synergie des médicaments , Contraction musculaire/effets des médicaments et des substances chimiques , Muscle droit de l'abdomen/effets des médicaments et des substances chimiques , Suxaméthonium/antagonistes et inhibiteurs
SÉLECTION CITATIONS
Détails de la recherche